Todd Morgan is a Genitourinary physician affiliated with University of Michigan. OpenAlex indexes 746 publications with 18,696 citations (h-index 71); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Urology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Sponsor: University of Michigan Rogel Cancer Center
Overall officialRecruitingNCT07645391 - Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
Sponsor: University of Michigan Rogel Cancer Center
Overall officialNot, yet, recruitingNCT07526545 - Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Sponsor: University of Michigan Rogel Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
8 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
2 NIH research awards on record, funded 2019–2025 per NIH RePORTER. The latest:
- Project 2 - Validation and clinical utility of a multiplex urine biomarker for identification of clinically significant prostate cancer
University of Michigan at Ann Arbor
FY2025$433,938P50CA186786 - Determining the clinical impact of gene expression testing in localized prostate cancer
University of Michigan at Ann Arbor
FY2024$164,834R01CA240991 - Determining the clinical impact of gene expression testing in localized prostate cancer
University of Michigan at Ann Arbor
FY2023$473,428R01CA240991
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Moshe Talpaz, MD
University of Michigan
William Herman, MD
University of Michigan
Max Wicha, MD
University of Michigan
Dinesh Khanna, MD
University of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”